🇨🇭
Western EuropeSwitzerland
Switzerland punches far above its weight in biotech, with Basel as a global pharmaceutical hub (Roche, Novartis). The Swiss biotech ecosystem benefits from exceptional talent, favorable tax policies, and proximity to major pharma headquarters.
Biotech Market Cap
$910.3B
Public Companies
37
Total Companies
328
30D Performance
+5.14%
BIOTECH MARKET CAP INDEX
$910.3B+3445.3%ALL
BIOTECH HUBS
BaselZurichGenevaLausanne
COMPANIES
| # | Company | Valuation |
|---|---|---|
| 1 |  | $280.3B |
| 2 |  | $217.2B |
| 3 |  | $184.0B |
| 4 |  | $49.8B |
| 5 |  | $43.6B |
| 6 |  | $37.2B |
| 7 |  | $30.6B |
| 8 |  | $17.2B |
| 9 |  | $7.6B |
| 10 |  | $5.4B |
| 11 |  | $5.3B |
| 12 |  | $5.3B |
| 13 |  | $4.6B |
| 14 |  | $3.9B |
| 15 |  | $3.2B |
| 16 |  | $2.1B |
| 17 |  | $2.0B |
| 18 |  | $2.0B |
| 19 |  | $1.7B |
| 20 | | $1.5B |
1–20 of 328
Page 1 of 17